Cardiac RehabilitationRECARDNCT06370611
Early Remote Rehabilitation to Improve Health of the Elderly After Cardiac Surgery. (RECARD Trial)
A study testing Early mobile health intervention supplemented by weekly calls from a physiotherapist in people with Cardiac Rehabilitation, run by Ivy susanne Modrau, MD at 2 sites in Denmark.
Trial summary
An increasing number of older patients undergo heart surgery. Despite seemingly successful outcomes, these vulnerable patients may face prolonged decreased functional capacity, reduced self-efficacy, and impaired quality of life after discharge. Read more about this study
- Who is it for?
- Ages 65 years and older
- Conditions the study is for
- Cardiac Rehabilitation
- What is being tested?
- Early mobile health intervention supplemented by weekly calls from a physiotherapist
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 118 participants
- Where
- 2 sitesDenmark
- Study dates
- 1 May 2024to 15 Aug 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 65 years and older
- All sexes
- No healthy volunteers
- Older adult
Who may be able to join
- Provision of signed and dated informed consent form
- Scheduled first-time heart surgery through median sternotomy
- Male or female, aged ≥ 65 years (The age criterion implies the exclusion of women of childbearing potential)
Who cannot join
- Medical conditions requiring referral to specialized rehabilitation (e.g., severe heart or lung failure, need for blood pressure monitoring during exercise)
- Emergent procedure
- Anticipated inability to perform intervention, study assessment procedures, or follow-up
- Participation in any other interventional clinical that may interfere with the outcome measures
Trial locations and contacts
2 sites in 1 country.
Denmark2 sites
Aarlborg University Hospital
Aalborg, 9000
Aarhus University Hospital
Aarhus, Denmark, 8200
About this study
Official title: Early REmote Rehabilitation to Improve Health of the Elderly After CARDiac Surgery. (RECARD Trial). A Bi-center, Prospective, Randomized, Open-label, Blinded Evaluation (PROBE) Trial
An increasing number of older patients undergo heart surgery. Despite seemingly successful outcomes, these vulnerable patients may face prolonged decreased functional capacity, reduced self-efficacy, and impaired quality of life after discharge. Early engagement in physical activity and education plays a key role in health and well-being after heart surgery The goal of this clinical trial is to evaluate the effectiveness of an app-based exercise program and weekly calls from a physiotherapist in the early stages after open heart surgery.
Eligible patients will be randomly assigned to either a control group receiving standard care or an intervention group, which will be introduced to an individually tailored exercise program as an addition to standard care.
Read more
Follow-up is planned with an out-patient visit six weeks after discharge and a telephone interview six months post-surgery.
All participants will undergo assessments at enrollment and during follow-up. Physical performance will be evaluated through physical tests. General well-being, quality of life, self-reported physical activity, and cost-effectiveness of the intervention will be assessed through questionnaires. Muscle health will be examined through blood sampling, CT scans, and muscle biopsies.
The primary endpoint is the 30-second Chair Stand Test serving as a measurement of physical function.
Read the detailed description
Hypotheses:
Primary: Early mobile health intervention at home supplemented by weekly calls from a physiotherapist after cardiac surgery improves functional outcomes, exercise tolerance, and quality of life in older patients.
Secondary:
- Cardiac surgery increases the prevalence and extent of sarcopenia in the elderly which can be mitigated by early mobile health intervention
- Sarcopenia on Chest Computed Tomography (CCT) is strongly correlated to functional outcome and quality of life following cardiac surgery
- Early mobile health intervention is feasible and cost-effective
Design:
This is a bi-center, prospective, randomized controlled, parallel, two-arm, open-label, blinded evaluation (PROBE) trial with a superiority design. The study population will consist of a representative group (n=120) of older patients scheduled for open heart surgery who fulfill the requirements according to inclusion and exclusion criteria. The patients will be recruited from 2 cardiac surgery centers in northern and central Denmark.
Patients are stratified after center and subsequently randomly allocated (1:1) to receive mobile health intervention as an adjunct to standard care (Intervention Group), or standard care alone (Control group) for 6 weeks after discharge. Follow-up is planned with an outpatient visit 6 weeks after discharge, and a telephone interview 6 months after surgery.
Patients in the intervention group receive a 6-week home-based CR using the ICURA app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist. The patients are equipped with a case including an ICURA -sensor with a charger, an illustrative quick guide, and a contact telephone number. According to the patient's preference, the app is either installed on their own mobile phone or provided on a separate mobile device.
The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, text message communication with patients, and a password-protected webpage for physiotherapists to customize training programs and track patient activity.
A few days after discharge, patients in the intervention group will receive the first call from the physiotherapist, to ensure, that the patient is using the ICURA app actively. The patients will receive two calls per week for the first two weeks and as required the following four weeks.
- Conditions
- Cardiac Rehabilitation
- Being tested
- Early mobile health intervention supplemented by weekly calls from a physiotherapist
- Keywords
- Cardiac Surgery, Mobile Health, Elderly, Exercise, Randomised Controlled Trial
- Medical subject headings
- Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Early mobile health intervention supplemented by weekly calls from a physiotherapistDevice
Also called ICURA
Six-week home-based rehabilitation program using the ICURA app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist.
The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, and a password-protected webpage for physiotherapists to customize training programs and track patient activity.
The patients will receive two calls from a physiotherapist per week for the first two weeks and as required the following four weeks.
| Study group | Role | What they receive |
|---|---|---|
| Early mobile health intervention | Active comparator | ICURA app and sensor-based technology, individualized training plan, and weekly calls from a physiotherapist in addition to standard care Receives: Device: Early mobile health intervention supplemented by weekly calls from a physiotherapist |
| Control | No intervention | Standard care consists of physiotherapy group education of about 10-15 minutes regarding mobilization, respiratory therapy, and sternal precautions after surgery. After surgery, phase I in-hospital rehabilitation consists of respiratory therapy, mobilization from supine and sitting position, and walking down a corridor. Prior to discharge, all patients are encouraged to undertake daily walks and resume activities of daily living, and engage in recommended moderate physical activity (Borg's scale 12-14). All patients are referred to CR in their municipality. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change (Δ) 30-second chair stand test (30CST) baseline vs. 6-week FU
Recording of the number of stands a person can complete from a chair without arms in 30 seconds
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
Secondary outcomes (16)
Change (Δ) in 10-meter Walk Test (10MWT) baseline vs. 6-week FU
Measurement of walking speed in meters per second over a 10-meter distance
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Difference in 6-minute Walk Test (6MWT) between groups at 6-week FU
Measurement of walking distance in 6 minutes.
Measured: 6 weeks (+/- 4 days) after discharge
Change (Δ) in WHO-5-score baseline vs. 6-week FU
5-item World Health Organization Well-Being Index (WHO-5), questionnaire assessing subjective well-being
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in ASS-2-score baseline vs. 6-week FU
Anxiety Symptom Scale-2 (ASS-2), questionnaire assessing anxiety
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in MDI-2-score baseline vs. 6-week FU
Major Depression Inventory-2 (MDI-2), questionnaire assessing depression
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in Self-reported Physical Activity baseline vs. 6-week FU
Questionnaire assessing self-reported physical activity
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in EuroQol-score baseline vs. 6-week FU
EuroQol-5-Dimension-5-Level Questionnaire (EQ-5D-5L), questionnaire assessing health-related quality of life
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change in skeletal muscle mass baseline vs. 6-week FU
Body composition analysis with artificial-intelligence-assisted medical image analysis (CT scan) (DAFS©, Veronoi Health Analytics, Vancouver, Canada) to assess quantity and quality of skeletal muscle.
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Cost-effectiveness analysis
Questionnaire assessing the cost-effectiveness of the intervention in comparison to usual care
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Changes in markers of musculoskeletal health through blood samples baseline vs. 6-week FU
Markers of muscle health: Myoglobin, Creatine Kinase (CK)
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of inflammation through blood samples baseline vs. 6-week FU
Inflammatory markers: White Cell Count (WCC), Platelet Count, Mean Platelet Volume (MPV), Immature Platelet Fraction (IPF), High-Sensitive C-Reactive Protein (hs-CRP)
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of nutrition through blood samples baseline vs. 6-week FU
Nutritional markers: Hemoglobin, Glycated Hemoglobin (HbA1c), fasting glucose, Albumin, Triglycerides, High-Density Lipoprotein (HDL), Low-Density Lipoprotein (LDL), Vitamin B12, Folate, 25-OH-Vitamin D2+D3
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of liver function through blood samples baseline vs. 6-week FU
Liver Function Markers: Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT)
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of kidney function through blood samples baseline vs. 6-week FU
Kidney Function Markers: Creatinine, estimated Glomerular Filtration Rate (eGFR)
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of hormone levels through blood samples baseline vs. 6-week FU
Hormonal Markers: Cortisol, Free/Total Testosterone, Sex Hormone Binding Globulin (SHBG), Insulin-like Growth Factor-1 (IGF-1)
Measured: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Assessment of muscle quality through obtainment of biopsies of the pectoralis major muscle at the surgery
Analysis of pectoralis major muscle biopsies
Measured: At surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Apr 2024
- Study start1 May 2024
- Primary completion15 Mar 2026
- Study completion15 Aug 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Cardiac RehabilitationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Bi-center, prospective, randomized, controlled, parallel (1:1), two-arm, open-label, blinded evaluation (PROBE) trial
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 118 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ivy susanne Modrau, MD
- Sponsor type
- University, hospital or other
- Collaborators
- Aalborg University Hospital
- Responsible party
- Sponsor-investigator, Ivy susanne Modrau, MD, Aarhus University Hospital Skejby
- Investigators
- Ivy S. Modrau, MD, dr.med., Study chair, Aarhus University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06370611
- Sponsor's protocol ID
- 2314027
- Acronym
- RECARD
- Status last verified
- Sep 2026
- First submitted
- 8 Apr 2024
- Last updated
- 9 Sep 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The participants of this study did not give written consent for their data to be shared publicly, so due to the sensitive nature of the research supporting data is not available.
Publications
Svidt P, Daugaard R, Lading T, Modrau IS. Changes in skeletal muscle and physical function after cardiac surgery: a prospective study. J Nutr Health Aging. 2026 Oct 3;30(12):100999. doi: 10.1016/j.jnha.2026.100999. Online ahead of print.
PubMed 42828917Daugaard R, Sorensen L, Ingemann-Molden S, Modrau IS. Early remote rehabilitation to improve health of the elderly after cardiac surgery - study protocol for a randomised trial. Dan Med J. 2025 Jun 21;72(7):A11240820. doi: 10.61409/A11240820.
PubMed 40600679
Study at a glance
From the registry record, last updated by the sponsor on 9 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Early REmote Rehabilitation to Improve Health of the Elderly After CARDiac Surgery. (RECARD Trial). A Bi-center, Prospective, Randomized, Open-label, Blinded Evaluation (PROBE) Trial
- ClinicalTrials.gov ID
- NCT06370611
- Acronym / sponsor ID
- RECARD / 2314027
- Conditions
- Cardiac Rehabilitation
- Keywords
- Cardiac Surgery, Mobile Health, Elderly, Exercise, Randomised Controlled Trial
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 118 participants (actual)
- Lead sponsor
- Ivy susanne Modrau, MDUniversity, hospital or other
- Collaborators
- Aalborg University Hospital
- Study start
- 1 May 2024 (actual)
- Primary completion
- 15 Mar 2026 (actual)
- Study completion
- 15 Aug 2026 (actual)
- First posted
- 17 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
An increasing number of older patients undergo heart surgery. Despite seemingly successful outcomes, these vulnerable patients may face prolonged decreased functional capacity, reduced self-efficacy, and impaired quality of life after discharge. Early engagement in physical activity and education plays a key role in health and well-being after heart surgery The goal of this clinical trial is to evaluate the effectiveness of an app-based exercise program and weekly calls from a physiotherapist in the early stages after open heart surgery.
Eligible patients will be randomly assigned to either a control group receiving standard care or an intervention group, which will be introduced to an individually tailored exercise program as an addition to standard care.
Follow-up is planned with an out-patient visit six weeks after discharge and a telephone interview six months post-surgery.
All participants will undergo assessments at enrollment and during follow-up. Physical performance will be evaluated through physical tests. General well-being, quality of life, self-reported physical activity, and cost-effectiveness of the intervention will be assessed through questionnaires. Muscle health will be examined through blood sampling, CT scans, and muscle biopsies.
The primary endpoint is the 30-second Chair Stand Test serving as a measurement of physical function.
Detailed description
Hypotheses:
Primary: Early mobile health intervention at home supplemented by weekly calls from a physiotherapist after cardiac surgery improves functional outcomes, exercise tolerance, and quality of life in older patients.
Secondary:
- Cardiac surgery increases the prevalence and extent of sarcopenia in the elderly which can be mitigated by early mobile health intervention
- Sarcopenia on Chest Computed Tomography (CCT) is strongly correlated to functional outcome and quality of life following cardiac surgery
- Early mobile health intervention is feasible and cost-effective
Design:
This is a bi-center, prospective, randomized controlled, parallel, two-arm, open-label, blinded evaluation (PROBE) trial with a superiority design. The study population will consist of a representative group (n=120) of older patients scheduled for open heart surgery who fulfill the requirements according to inclusion and exclusion criteria. The patients will be recruited from 2 cardiac surgery centers in northern and central Denmark.
Patients are stratified after center and subsequently randomly allocated (1:1) to receive mobile health intervention as an adjunct to standard care (Intervention Group), or standard care alone (Control group) for 6 weeks after discharge. Follow-up is planned with an outpatient visit 6 weeks after discharge, and a telephone interview 6 months after surgery.
Patients in the intervention group receive a 6-week home-based CR using the ICURA app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist. The patients are equipped with a case including an ICURA -sensor with a charger, an illustrative quick guide, and a contact telephone number. According to the patient's preference, the app is either installed on their own mobile phone or provided on a separate mobile device.
The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, text message communication with patients, and a password-protected webpage for physiotherapists to customize training programs and track patient activity.
A few days after discharge, patients in the intervention group will receive the first call from the physiotherapist, to ensure, that the patient is using the ICURA app actively. The patients will receive two calls per week for the first two weeks and as required the following four weeks.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Bi-center, prospective, randomized, controlled, parallel (1:1), two-arm, open-label, blinded evaluation (PROBE) trial
| Arm | Type | Receives |
|---|---|---|
| Early mobile health intervention | Active comparator | Device: Early mobile health intervention supplemented by weekly calls from a physiotherapistICURA app and sensor-based technology, individualized training plan, and weekly calls from a physiotherapist in addition to standard care |
| Control | No intervention | –Standard care consists of physiotherapy group education of about 10-15 minutes regarding mobilization, respiratory therapy, and sternal precautions after surgery. After surgery, phase I in-hospital rehabilitation consists of respiratory therapy, mobilization from supine and sitting position, and walking down a corridor. Prior to discharge, all patients are encouraged to undertake daily walks and resume activities of daily living, and engage in recommended moderate physical activity (Borg's scale 12-14). All patients are referred to CR in their municipality. |
Who may qualify
- Ages
- 65 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Older adult
Key inclusion criteria (3 listed)
- Provision of signed and dated informed consent form
- Scheduled first-time heart surgery through median sternotomy
- Male or female, aged ≥ 65 years (The age criterion implies the exclusion of women of childbearing potential)
Key exclusion criteria (4 listed)
- Medical conditions requiring referral to specialized rehabilitation (e.g., severe heart or lung failure, need for blood pressure monitoring during exercise)
- Emergent procedure
- Anticipated inability to perform intervention, study assessment procedures, or follow-up
- Participation in any other interventional clinical that may interfere with the outcome measures
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Early mobile health intervention supplemented by weekly calls from a physiotherapistAlso: ICURASix-week home-based rehabilitation program using the ICURA app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist. The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, and a password-protected webpage for physiotherapists to customize training programs and track patient activity. The patients will receive two calls from a physiotherapist per week for the first two weeks and as required the following four weeks. | Device | Early mobile health intervention |
Primary outcome
Change (Δ) 30-second chair stand test (30CST) baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery
Recording of the number of stands a person can complete from a chair without arms in 30 seconds
16 secondary outcomes
Change (Δ) in 10-meter Walk Test (10MWT) baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Difference in 6-minute Walk Test (6MWT) between groups at 6-week FU
Time frame: 6 weeks (+/- 4 days) after discharge
Change (Δ) in WHO-5-score baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in ASS-2-score baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in MDI-2-score baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in Self-reported Physical Activity baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change (Δ) in EuroQol-score baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Change in skeletal muscle mass baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Cost-effectiveness analysis
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge and 6 months after surgery
Changes in markers of musculoskeletal health through blood samples baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of inflammation through blood samples baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of nutrition through blood samples baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of liver function through blood samples baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of kidney function through blood samples baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Changes in markers of hormone levels through blood samples baseline vs. 6-week FU
Time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after discharge
Assessment of muscle quality through obtainment of biopsies of the pectoralis major muscle at the surgery
Time frame: At surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Sep 2026.
- Derived from this study: PubMed 42828917Svidt P, Daugaard R, Lading T, Modrau IS. Changes in skeletal muscle and physical function after cardiac surgery: a prospective study. J Nutr Health Aging. 2026 Oct 3;30(12):100999. doi: 10.1016/j.jnha.2026.100999. Online ahead of print.
- Derived from this study: PubMed 40600679Daugaard R, Sorensen L, Ingemann-Molden S, Modrau IS. Early remote rehabilitation to improve health of the elderly after cardiac surgery - study protocol for a randomised trial. Dan Med J. 2025 Jun 21;72(7):A11240820. doi: 10.61409/A11240820.
- Individual participant dataSharing planned: No. The participants of this study did not give written consent for their data to be shared publicly, so due to the sensitive nature of the research supporting data is not available.
Related trials for Cardiac Rehabilitation
Recruiting
Remote Rehabilitation in Patients With HFpEF (PATRON-HF)
Heart Failure With Preserved Ejection Fraction
Recruiting
Exercise and Diet Supplements for Older Patients Undergoing TAVI: the IRON-TAVI Trial
Aortic Stenosis Disease, Aortic Stenosis Symptomatic
Not yet recruiting
King's Theory-Based Multicomponent Interventions in Heart Failure Patient Rehabilitation
Heart Failure, Cardiac Rehabilitation
Recruiting
Rehabilitation Program for People With Methamphetamine-Associated Cardiopulmonary Conditions
Methamphetamine-Associated Heart Failure, Methamphetamine-Associated Pulmonary Arterial Hypertension
Recruiting
Impact of a Tailored Digital Intervention on Sedentary Behaviour and Physical Health in Long-term Cardiac Rehabilitation Patients
Cardiovascular Diseases (CVD), Coronary Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Ivy S. Modrau, MD, dr.med. study chair
Aarhus University Hospital
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Early mobile health intervention supplemented by weekly calls from a physiotherapist in people with Cardiac Rehabilitation, run by Ivy susanne Modrau, MD at 2 sites in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change (Δ) 30-second chair stand test (30CST) baseline vs. 6-week FU (time frame: 1-7 days prior to surgery and 6 weeks (+/- 4 days) after surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06370611, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2026.